Shares of pharmaceutical giant Amgen (AMGN) are attempting to bounce back after suffering a steep drop of 7.1% yesterday.

The excitement around the new weight-loss industry is overtaking other disease areas and portfolios for publicly traded ...

Pfizer's drug approvals and advertising revenue could be affected by RFK Jr.'s potential appointment. See why PFE stock is a ...

Mankind Pharma announced the pledge of nearly 40 per cent of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited, ...

Trump previously said RFK Jr. would have carte blanche to "go wild" on health-related matters if he became part of Trump's ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $35.2, along ...

We recently published a list of 10 Best Multibagger Stocks To Buy Heading into 2025. In this article, we are going to take a ...

On Wednesday, Sigachi Industries Ltd. made its Q2FY25 and H1FY25 announcements. When compared to Q2FY24, when net revenues ...

Uncover hidden gems in the stock market with the 'Undercovered Dozen' series featuring undervalued stocks with potential for ...

We recently published a list of 10 Top Performing European Stocks Heading into 2025. In this article, we are going to take a ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

The third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...